Ginkgo Bioworks Inc. (DNA)
NYSE: DNA
· Real-Time Price · USD
12.46
-0.44 (-3.41%)
At close: Aug 15, 2025, 10:03 AM
Company Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming.
Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.
Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform.
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Ginkgo Bioworks Inc.
| Country | United States |
| IPO Date | Apr 19, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 834 |
| CEO | Jason Kelly |
Contact Details
Address: 27 Drydock Avenue Boston, Massachusetts United States | |
| Website | https://www.ginkgobioworks.com |
Stock Details
| Ticker Symbol | DNA |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001830214 |
| CUSIP Number | 37611X209 |
| ISIN Number | US37611X2099 |
| Employer ID | 87-2652913 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jason Kelly Ph.D. | Founder, Chief Executive Officer & Director |
| Bartholomew Canton Ph.D. | Founder, Chief Technology Officer & Secretary |
| Dr. Reshma P. Shetty | Founder, President, Chief Operating Officer & Director |
| Mark E. Dmytruk | Chief Financial Officer |
| Austin Che Ph.D. | Founder, Head of Strategy & Treasurer |
| Daniel Marshall | Senior Manager of Communications & Ownership |
| Karen Tepichin | General Counsel & Secretary |
| Samantha Sutton | Head of People |
| Steven P. Coen CPA | Chief Accounting Officer |
| Thomas Knight Jr. | Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 07, 2025 | S-3 | Filing |
| Aug 07, 2025 | 10-Q | Quarterly Report |
| Aug 07, 2025 | 8-K | Current Report |
| Jul 29, 2025 | SCHEDULE 13G | Filing |
| Jul 21, 2025 | 4 | Filing |
| Jul 17, 2025 | SCHEDULE 13G | Filing |
| Jun 13, 2025 | 4 | Filing |
| Jun 13, 2025 | 4 | Filing |
| Jun 13, 2025 | 4 | Filing |
| Jun 13, 2025 | 4 | Filing |